Hüpofüüsi ja hüpotaalamuse hormoonid ja nende analoogid, süsteemse kasutusega kortikosteroidid, luu mineralisatsiooni mõjutavad ravimid, kilpnäärme preparaadid

This is a mandatory-compliance document for a North Estonia Regional Hospital pharmaceutical tender that simply requires bidders to confirm they will not use Russian-linked subcontractors (>10% of contract value) and, if bidding as a consortium, to upload a joint-bid power-of-attorney—no product specs, qualifications or award criteria are disclosed here, so firms must check the full tender file before deciding to bid.

This document is merely the bidder’s declaration form—mandatory to sign and submit—stating that the supplier has read the full tender dossier, accepts all obligations and risks, and holds its offer open for 3 months; it contains no product specifications, qualification criteria or evaluation details, so firms must consult the separate procurement documents to decide whether to bid.

Submit a fully-completed “289193 Technical offer/unit-prices” Excel sheet listing every required hormone/corticosteroid/thyroid drug with your proposed EXW unit price (mandatory), and ensure you can supply the exact ATC-coded medicines in the stated pharmaceutical forms, strengths and pack-sizes for the three Estonian hospitals up to the indicated maximum volumes.

North Estonia Regional Hospital is running a 100% price-only tender (no e-auction) for endocrine drugs—alfatüreotropin, desmopressin, pegvisomant, etc.—split into lots; bidders must simply quote the lowest unit prices ex-VAT in the mandatory Excel template and be ready for a draw if prices tie, so any licensed wholesaler or manufacturer able to supply these prescription-only medicines on the Estonian market should bid.

Open Estonian tender by North-Estonian Regional Hospital for supply of pituitary/hypothalamic hormones, systemic corticosteroids, bone-mineralisation and thyroid drugs split into 22 lots; bidders must submit an electronic ESPD (no paper) and prove general exclusion/qualification grounds—no stated minimum turnover, staff or prior contract value, so any EU-licensed wholesaler/manufacturer holding valid medicinal-product authorisations can bid.

This draft framework-agreement contract for hospital medicines (pituitary/hypothalamic hormones, systemic corticosteroids, bone-mineralisation drugs, thyroid preparations) merely sets out general delivery terms and does not specify any mandatory technical requirements, qualification criteria or award criteria—so suppliers should wait for the full procurement documents (RHAD 289193) to decide whether to bid.

This is a framework-procurement for the mandatory, on-catalogue supply of 25 specific hospital-grade pituitary, corticosteroid, thyroid and bone-mineralisation medicines (exact ATC codes, active substances, forms and strengths listed) to North Estonia Regional Hospital and two partner hospitals, so only wholesalers/manufacturers holding valid marketing authorisations and state wholesale licences for the required Estonian-registered packs should consider bidding.